Premier Health of America Inc
XTSX:PHA
Premier Health of America Inc
XTSX:PHA
Price:
0.015
CAD
Market Closed
Market Cap:
CA$832.7k
Relative Value
There is not enough data to reliably calculate the relative value of PHA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHA
Relative Value
Base Case
Not Available
Multiples Across Competitors
PHA Competitors Multiples
Premier Health of America Inc Competitors
Premier Health of America Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Premier Health of America Inc
XTSX:PHA
|
832.7k CAD | 0 | -0.1 | 4.1 | -0.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD | 0.2 | 56.4 | 14.2 | 14.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.7B USD | 0.3 | 12.6 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR | 0.3 | 12.5 | 8 | 10.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.8B EUR | 1.3 | 25.3 | 11 | 16.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24B EUR | 1.2 | 33.3 | 10.5 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.5B USD | 1.7 | 27.4 | 14.7 | 20.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.8B USD | 2.1 | 23 | 12.6 | 17.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 0.6 | 16.3 | 6.4 | 13.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.1B USD | 14.6 | -33 | -34.8 | -31.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.7 | 13.7 | 7.2 | 9.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
